Quick Answer
SkinHealth Systems Inc. reported Total Revenue of $300.79 million for the year ending 2025.
- SkinHealth Systems Inc. showed a decrease of -10.0% in Total Revenue from 2024 to 2025.
- This data is from SkinHealth Systems Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $14.12 million | Q3 2020: $34.56 million | Q1 2021: $47.54 million | Q2 2021: $66.51 million | Q3 2021: $68.15 million | Q1 2022: $75.42 million | Q2 2022: $103.54 million | Q3 2022: $88.79 million | Q1 2023: $86.28 million | Q2 2023: $117.48 million | Q3 2023: $97.41 million | Q1 2024: $81.40 million | Q2 2024: $90.59 million | Q3 2024: $78.80 million | Q1 2025: $69.58 million | Q2 2025: $78.19 million | Q3 2025: $70.66 million.
- Over the full 7 years of available data (2019 to 2025), SkinHealth Systems Inc.'s Total Revenue has grown by 80.5%.
- Historical annual values: Fiscal year 2025: $300.79 million | Fiscal year 2024: $334.29 million | Fiscal year 2023: $397.99 million | Fiscal year 2022: $365.88 million | Fiscal year 2021: $260.09 million | Fiscal year 2020: $119.09 million | Fiscal year 2019: $166.62 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: